1
|
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
|
Eur Respir J
|
2013
|
8.39
|
2
|
Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation.
|
Science
|
2004
|
6.28
|
3
|
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis.
|
J Clin Invest
|
2003
|
4.08
|
4
|
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression.
|
J Allergy Clin Immunol
|
2003
|
2.98
|
5
|
T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma.
|
J Allergy Clin Immunol
|
2009
|
2.54
|
6
|
Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells.
|
J Immunol
|
2009
|
2.42
|
7
|
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.
|
J Allergy Clin Immunol
|
2012
|
2.24
|
8
|
Increased IL-33 expression by epithelial cells in bronchial asthma.
|
J Allergy Clin Immunol
|
2010
|
2.17
|
9
|
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.
|
J Allergy Clin Immunol
|
2006
|
2.00
|
10
|
Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA.
|
Crit Care Med
|
2002
|
1.93
|
11
|
Chlorine-induced injury to the airways in mice.
|
Am J Respir Crit Care Med
|
2003
|
1.79
|
12
|
Upper airway muscle inflammation and denervation changes in obstructive sleep apnea.
|
Am J Respir Crit Care Med
|
2004
|
1.75
|
13
|
Role of transforming growth factor-β in airway remodeling in asthma.
|
Am J Respir Cell Mol Biol
|
2010
|
1.71
|
14
|
IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation.
|
J Immunol
|
2010
|
1.65
|
15
|
Remodeling in asthma.
|
J Allergy Clin Immunol
|
2011
|
1.64
|
16
|
S epsilon S mu and S epsilon S gamma switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination.
|
J Immunol
|
2003
|
1.61
|
17
|
Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction.
|
J Allergy Clin Immunol
|
2009
|
1.52
|
18
|
Differences in airway remodeling between subjects with severe and moderate asthma.
|
J Allergy Clin Immunol
|
2005
|
1.52
|
19
|
Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma.
|
J Allergy Clin Immunol
|
2005
|
1.49
|
20
|
Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse.
|
Am J Respir Cell Mol Biol
|
2003
|
1.49
|
21
|
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
|
J Allergy Clin Immunol
|
2006
|
1.44
|
22
|
T helper type 2 cytokine receptors and associated transcription factors GATA-3, c-MAF, and signal transducer and activator of transcription factor-6 in induced sputum of atopic asthmatic patients.
|
Chest
|
2003
|
1.44
|
23
|
Vitamin D deficiency as a strong predictor of asthma in children.
|
Int Arch Allergy Immunol
|
2011
|
1.44
|
24
|
Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
|
J Allergy Clin Immunol
|
2006
|
1.43
|
25
|
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.
|
Thorax
|
2007
|
1.42
|
26
|
Increased expression of ADAM33 and ADAM8 with disease progression in asthma.
|
J Allergy Clin Immunol
|
2007
|
1.40
|
27
|
IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.
|
J Allergy Clin Immunol
|
2006
|
1.37
|
28
|
Airway remodeling in asthma.
|
Allergol Int
|
2007
|
1.36
|
29
|
Differences in airway cytokine profile in severe asthma compared to moderate asthma.
|
Chest
|
2007
|
1.36
|
30
|
Distribution of nitric oxide synthase in normal and cirrhotic human liver.
|
Proc Natl Acad Sci U S A
|
2002
|
1.33
|
31
|
Myosin, transgelin, and myosin light chain kinase: expression and function in asthma.
|
Am J Respir Crit Care Med
|
2008
|
1.27
|
32
|
IL-9 in allergic inflammation.
|
Int Arch Allergy Immunol
|
2004
|
1.27
|
33
|
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics.
|
J Allergy Clin Immunol
|
2003
|
1.23
|
34
|
Remodeling in asthma.
|
Proc Am Thorac Soc
|
2009
|
1.20
|
35
|
Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma.
|
J Allergy Clin Immunol
|
2009
|
1.18
|
36
|
A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma.
|
J Allergy Clin Immunol
|
2002
|
1.16
|
37
|
Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa.
|
J Allergy Clin Immunol
|
2005
|
1.16
|
38
|
Airway remodeling in asthma.
|
Curr Opin Pharmacol
|
2010
|
1.16
|
39
|
Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
|
J Allergy Clin Immunol
|
2004
|
1.16
|
40
|
Th17-associated cytokines promote human airway smooth muscle cell proliferation.
|
FASEB J
|
2012
|
1.14
|
41
|
Airway remodelling in asthma: from benchside to clinical practice.
|
Can Respir J
|
2010
|
1.11
|
42
|
Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma.
|
J Allergy Clin Immunol
|
2010
|
1.11
|
43
|
Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis.
|
J Immunol
|
2007
|
1.10
|
44
|
Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I.
|
J Allergy Clin Immunol
|
2007
|
1.10
|
45
|
CCR3 expression and function in asthmatic airway smooth muscle cells.
|
J Immunol
|
2005
|
1.08
|
46
|
IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells.
|
J Immunol
|
2004
|
1.07
|
47
|
CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease.
|
Respir Res
|
2011
|
1.07
|
48
|
T helper 17 cells in airway diseases: from laboratory bench to bedside.
|
Chest
|
2013
|
1.06
|
49
|
The immunomodulatory actions of prostaglandin E2 on allergic airway responses in the rat.
|
J Immunol
|
2002
|
1.05
|
50
|
Immunopathology of atopic dermatitis.
|
J Allergy Clin Immunol
|
2006
|
1.05
|
51
|
Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide.
|
J Allergy Clin Immunol
|
2005
|
1.05
|
52
|
Images in allergy and immunology: neutrophils in asthma.
|
J Allergy Clin Immunol
|
2007
|
1.02
|
53
|
Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13.
|
J Allergy Clin Immunol
|
2003
|
1.01
|
54
|
TNF-alpha and IFN-gamma inversely modulate expression of the IL-17E receptor in airway smooth muscle cells.
|
Am J Physiol Lung Cell Mol Physiol
|
2006
|
1.01
|
55
|
Effect of HFA-flunisolide on peripheral lung inflammation in asthma.
|
J Allergy Clin Immunol
|
2003
|
1.00
|
56
|
Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production.
|
J Allergy Clin Immunol
|
2004
|
0.99
|
57
|
5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin.
|
J Allergy Clin Immunol
|
2003
|
0.99
|
58
|
Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults.
|
Lancet
|
2004
|
0.99
|
59
|
TH17 cytokines induce human airway smooth muscle cell migration.
|
J Allergy Clin Immunol
|
2011
|
0.99
|
60
|
Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples.
|
J Allergy Clin Immunol
|
2010
|
0.97
|
61
|
Mucin overproduction in chronic inflammatory lung disease.
|
Can Respir J
|
2006
|
0.97
|
62
|
ATG5, autophagy and lung function in asthma.
|
Autophagy
|
2012
|
0.96
|
63
|
Marked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients With chronic bronchitis with obstruction.
|
Chest
|
2003
|
0.96
|
64
|
Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease.
|
Respir Res
|
2011
|
0.96
|
65
|
Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells.
|
J Clin Immunol
|
2012
|
0.96
|
66
|
Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery.
|
Laryngoscope
|
2002
|
0.95
|
67
|
Obstructive sleep apnea syndrome and inflammation.
|
J Allergy Clin Immunol
|
2005
|
0.94
|
68
|
Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion.
|
J Allergy Clin Immunol
|
2007
|
0.93
|
69
|
Genetic deletion of IL-17A reduces cigarette smoke-induced inflammation and alveolar type II cell apoptosis.
|
Am J Physiol Lung Cell Mol Physiol
|
2013
|
0.92
|
70
|
IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells.
|
Respir Res
|
2013
|
0.92
|
71
|
Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis.
|
J Allergy Clin Immunol
|
2004
|
0.92
|
72
|
Human airway smooth muscle cells express the high affinity receptor for IgE (Fc epsilon RI): a critical role of Fc epsilon RI in human airway smooth muscle cell function.
|
J Immunol
|
2005
|
0.92
|
73
|
Genetic and histologic evidence for autophagy in asthma pathogenesis.
|
J Allergy Clin Immunol
|
2011
|
0.91
|
74
|
Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma.
|
Am J Respir Crit Care Med
|
2002
|
0.91
|
75
|
Inflammation and remodeling of the sinus mucosa in children and adults with chronic sinusitis.
|
Laryngoscope
|
2003
|
0.90
|
76
|
Role of airway smooth muscle in airway remodeling.
|
J Allergy Clin Immunol
|
2005
|
0.90
|
77
|
Downregulation of a disintegrin and metalloproteinase 33 by IFN-gamma in human airway smooth muscle cells.
|
J Allergy Clin Immunol
|
2006
|
0.90
|
78
|
Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio.
|
J Allergy Clin Immunol
|
2006
|
0.89
|
79
|
Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airways disease.
|
J Allergy Clin Immunol
|
2002
|
0.89
|
80
|
Symposium on obesity and asthma - November 2, 2006.
|
Can Respir J
|
2007
|
0.89
|
81
|
Mycoplasma in severe asthma.
|
J Allergy Clin Immunol
|
2006
|
0.88
|
82
|
Obesity, allergy and immunology.
|
J Allergy Clin Immunol
|
2005
|
0.88
|
83
|
Interferon-gamma-dependent inhibition of late allergic airway responses and eosinophilia by CD8+ gammadelta T cells.
|
Immunology
|
2007
|
0.88
|
84
|
The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
|
J Immunol
|
2003
|
0.88
|
85
|
Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
|
J Pharmacol Exp Ther
|
2004
|
0.88
|
86
|
Fibroblast growth factor-2 is a sputum remodeling biomarker of severe asthma.
|
J Asthma
|
2013
|
0.88
|
87
|
Autocrine-regulated airway smooth muscle cell migration is dependent on IL-17-induced growth-related oncogenes.
|
J Allergy Clin Immunol
|
2012
|
0.88
|
88
|
CD8+ alphabeta T cells can mediate late airway responses and airway eosinophilia in rats.
|
J Allergy Clin Immunol
|
2004
|
0.87
|
89
|
IL-17A and IL-17F expression in B lymphocytes.
|
Int Arch Allergy Immunol
|
2011
|
0.87
|
90
|
Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa.
|
J Allergy Clin Immunol
|
2005
|
0.87
|
91
|
Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration.
|
J Immunol
|
2013
|
0.87
|
92
|
Identification of ATPAF1 as a novel candidate gene for asthma in children.
|
J Allergy Clin Immunol
|
2011
|
0.86
|
93
|
Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis.
|
Can Respir J
|
2005
|
0.86
|
94
|
Yin-Yang 1 regulates effector cytokine gene expression and T(H)2 immune responses.
|
J Allergy Clin Immunol
|
2008
|
0.86
|
95
|
Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells.
|
FASEB J
|
2012
|
0.86
|
96
|
Resident CD8+ T cells suppress CD4+ T cell-dependent late allergic airway responses.
|
J Allergy Clin Immunol
|
2005
|
0.86
|
97
|
Long-term pathologic consequences of acute irritant-induced asthma.
|
J Allergy Clin Immunol
|
2009
|
0.85
|
98
|
The effects of CD8+gammadelta T cells on late allergic airway responses and airway inflammation in rats.
|
J Allergy Clin Immunol
|
2003
|
0.85
|
99
|
CC and CXC chemokines induce airway smooth muscle proliferation and survival.
|
J Immunol
|
2011
|
0.85
|
100
|
Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therapy.
|
Pediatrics
|
2002
|
0.85
|
101
|
Asthma phenotypes and endotypes.
|
Curr Opin Pulm Med
|
2013
|
0.85
|
102
|
Severe asthma.
|
J Allergy Clin Immunol
|
2006
|
0.85
|
103
|
IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves.
|
Vet Immunol Immunopathol
|
2004
|
0.84
|
104
|
Advances in mechanisms of allergy.
|
J Allergy Clin Immunol
|
2003
|
0.84
|
105
|
Disconnect between sputum neutrophils and other measures of airway inflammation in asthma.
|
Eur Respir J
|
2013
|
0.84
|
106
|
Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways.
|
J Allergy Clin Immunol
|
2009
|
0.84
|
107
|
Vitamin D deficiency and severe asthma.
|
Pharmacol Ther
|
2013
|
0.84
|
108
|
Effect of Th2 type cytokines on hCLCA1 and mucus expression in cystic fibrosis airways.
|
J Cyst Fibros
|
2010
|
0.83
|
109
|
Images in allergy and immunology: role of eosinophils in airway remodeling.
|
J Allergy Clin Immunol
|
2007
|
0.83
|
110
|
Psychologic distress and maladaptive coping styles in patients with severe vs moderate asthma.
|
Chest
|
2010
|
0.83
|
111
|
Contribution of the distal lung to the pathologic and physiologic changes in asthma: potential therapeutic target Roger S. Mitchell lecture.
|
Chest
|
2003
|
0.83
|
112
|
Increased glucocorticoid receptor-beta expression, but not decreased histone deacetylase 2, in severe asthma.
|
J Allergy Clin Immunol
|
2006
|
0.83
|
113
|
Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils.
|
Respir Res
|
2013
|
0.83
|
114
|
Expression and regulation of CCR1 by airway smooth muscle cells in asthma.
|
J Immunol
|
2008
|
0.83
|
115
|
Increased T-cell survival by structural bronchial cells derived from asthmatic subjects cultured in an engineered human mucosa.
|
J Allergy Clin Immunol
|
2008
|
0.82
|
116
|
Aryl hydrocarbon receptor-dependent retention of nuclear HuR suppresses cigarette smoke-induced cyclooxygenase-2 expression independent of DNA-binding.
|
PLoS One
|
2013
|
0.82
|
117
|
IL-8 production in response to cigarette smoke is decreased in epithelial cells from COPD patients.
|
Pulm Pharmacol Ther
|
2013
|
0.82
|
118
|
Very important pharmacogene summary for VDR.
|
Pharmacogenet Genomics
|
2012
|
0.82
|
119
|
Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients.
|
Can Respir J
|
2006
|
0.82
|
120
|
New insights into the pathophysiology of the small airways in asthma.
|
Clin Chest Med
|
2006
|
0.82
|
121
|
The role of the distal lung in asthma.
|
Semin Respir Crit Care Med
|
2002
|
0.82
|
122
|
Local isotype switching to IgE in airway mucosa.
|
J Allergy Clin Immunol
|
2005
|
0.82
|
123
|
T(H)2 cytokine expression in atopic children with otitis media with effusion.
|
J Allergy Clin Immunol
|
2002
|
0.82
|
124
|
Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis.
|
Laryngoscope
|
2003
|
0.82
|
125
|
T1 and T2 ADAM33 single nucleotide polymorphisms and the risk of childhood asthma in a Saudi Arabian population: a pilot study.
|
Ann Saudi Med
|
2012
|
0.81
|
126
|
Steroid-insensitive ERK1/2 activity drives CXCL8 synthesis and neutrophilia by airway smooth muscle.
|
Am J Respir Cell Mol Biol
|
2011
|
0.81
|
127
|
Molecular response of nasal mucosa to therapeutic exposure to broad-band ultraviolet radiation.
|
J Cell Mol Med
|
2008
|
0.81
|
128
|
Interaction between endothelial heme oxygenase-2 and endothelin-1 in altered aortic reactivity after hypoxia in rats.
|
Am J Physiol Heart Circ Physiol
|
2004
|
0.81
|
129
|
Personalized medicine for asthma: Are we there yet?
|
Ann Thorac Med
|
2012
|
0.80
|
130
|
CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients.
|
Lab Invest
|
2002
|
0.80
|
131
|
Expression of interleukin (IL)-5 and IL-9 receptors on neutrophils of horses with heaves.
|
Vet Immunol Immunopathol
|
2005
|
0.80
|
132
|
Eosinophils induce airway smooth muscle cell proliferation.
|
J Clin Immunol
|
2012
|
0.80
|
133
|
Increased expression of the calcium-activated chloride channel hCLCA1 in airways of patients with obstructive chronic bronchitis.
|
Can Respir J
|
2005
|
0.79
|
134
|
Up-Regulation of Interleukin-9 and the Interleukin-9-Associated Calcium-Activated Chloride Channel hCLCA1 in Nasal Mucosa Following In Vivo Allergen Challenge.
|
Allergy Asthma Clin Immunol
|
2007
|
0.79
|
135
|
NOS 1 is required for allergen-induced expression of NOS 2 in mice.
|
Int Arch Allergy Immunol
|
2005
|
0.79
|
136
|
Steroids and extracellular signal-regulated kinase 1/2 activity suppress activating transcription factor 3 expression in patients with severe asthma.
|
J Allergy Clin Immunol
|
2011
|
0.79
|
137
|
Airway remodeling in allergen-challenged Brown Norway rats: distribution of proteoglycans.
|
Am J Physiol Lung Cell Mol Physiol
|
2005
|
0.79
|
138
|
Cytokine profile of chronic sinusitis in patients with cystic fibrosis.
|
Arch Otolaryngol Head Neck Surg
|
2002
|
0.78
|
139
|
Appraising the small airways in asthma.
|
Curr Opin Pulm Med
|
2012
|
0.78
|
140
|
Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines.
|
Clin Immunol
|
2006
|
0.78
|
141
|
Koilocytosis in oral squamous cell carcinoma: what does it mean?
|
J Otolaryngol
|
2007
|
0.78
|
142
|
Quality of bronchial biopsies for morphology study and cell sampling: a comparison of asthmatic and healthy subjects.
|
Can Respir J
|
2008
|
0.78
|
143
|
Th-17 cell-related cytokines' potential role in the pathogenesis of severe asthma.
|
J Asthma
|
2008
|
0.77
|
144
|
CD4+ T cells migrate from airway to bone marrow after antigen inhalation in rats.
|
J Allergy Clin Immunol
|
2004
|
0.77
|
145
|
Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
|
Allergol Int
|
2008
|
0.77
|
146
|
Are leukocytes in asthmatic patients aging faster? A study of telomere length and disease severity.
|
J Allergy Clin Immunol
|
2013
|
0.77
|
147
|
Asthma endotypes: the right direction towards personalized medicine for asthma.
|
Expert Rev Clin Immunol
|
2012
|
0.76
|
148
|
Differences in MAP kinase phosphorylation in response to mechanical strain in asthmatic fibroblasts.
|
Respir Res
|
2006
|
0.76
|
149
|
The effects of IL-5 on airway physiology and inflammation in rats.
|
J Allergy Clin Immunol
|
2003
|
0.76
|
150
|
Immune supplementation and immune modulation with intravenous immunoglobulin.
|
J Allergy Clin Immunol
|
2005
|
0.76
|
151
|
Local induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjects.
|
Allergol Int
|
2009
|
0.76
|
152
|
Relationship between Asthma and Rhinitis: Epidemiologic, Pathophysiologic, and Therapeutic Aspects.
|
Allergy Asthma Clin Immunol
|
2005
|
0.75
|
153
|
Managing asthma during pregnancy: what information do we need to optimize care?
|
Am J Respir Crit Care Med
|
2011
|
0.75
|
154
|
Challeges in the management of severe asthma: role of current and future therapies.
|
Curr Pharm Des
|
2011
|
0.75
|
155
|
T-cell proliferation induced by local application of LPS in the nasal mucosa of nonatopic children.
|
J Allergy Clin Immunol
|
2002
|
0.75
|
156
|
Transcription factors in allergic diseases.
|
J Allergy Clin Immunol
|
2007
|
0.75
|
157
|
An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases.
|
Ann Am Thorac Soc
|
2017
|
0.75
|
158
|
Role of inflammatory T cells and eosinophils in chronic rhinosinusitis.
|
Clin Allergy Immunol
|
2007
|
0.75
|
159
|
Chemokine expression in allergic diseases.
|
J Allergy Clin Immunol
|
2006
|
0.75
|
160
|
Protein nitration in chronic sinusitis and nasal polyposis: role of eosinophils.
|
Otolaryngol Head Neck Surg
|
2004
|
0.75
|
161
|
Airway epithelial cells in asthma.
|
J Allergy Clin Immunol
|
2007
|
0.75
|
162
|
Toll-like receptors and atopy.
|
J Allergy Clin Immunol
|
2005
|
0.75
|
163
|
Involvement of lymphocytes in asthma and allergic diseases: a genetic point of view.
|
Curr Opin Allergy Clin Immunol
|
2013
|
0.75
|
164
|
Images in allergy and immunology: regulatory T cells in allergic disease.
|
J Allergy Clin Immunol
|
2007
|
0.75
|
165
|
Modulation of allergic response in nasal mucosa by antisense oligodeoxynucleotides for IL-4.
|
J Allergy Clin Immunol
|
2003
|
0.75
|
166
|
Selective irrigation of the sinuses in the management of chronic rhinosinusitis refractory to medical therapy: a promising start.
|
J Otolaryngol
|
2004
|
0.75
|